andy,i typed mesenchymal precursor cells into pubmed and turned up 1052 results.
Msb is a work in progress ,its difficult to make assumptions based on trials involving 100 or so patients hence the need for phase 3 trials (1500 patients ).
My understanding is that there will be publications and there will be peer reviews.
I believe that the share price accurately reflects these processes and that's why the company is values 1.6 bil and not 20 bil.
i value your thoughts and yet my view is that there is enough on the table now to warrant a punt on the prof and his team
inFact ,and for the record , "I'M ALL IN !!".
GO U GOOD THING !!!!!
(FELLOW MESOPHILES PLEASE DYOR!!!!!!)
GO THE SWANS!!
setting the record straight, page-4
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |